Clinical trial

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

NCT00143624

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Rosiglitazone maleate Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-06-01

PhaseNA

Conditions

Atherosclerosisverified · MONDO: atherosclerosis

HIV Infectionsunresolved

Interventions

Rosiglitazone maleateDRUG

PlaceboDRUG

Sponsors & collaborators

University of British Columbialead sponsor

Mapped research locations

VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00143624 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.